Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

SEMIRA collaborators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences